OPKO Health, Inc. Marketable Securities (Current)
OPKO Health, Inc. (OPK) had Marketable Securities (Current) of $15.63 million as of 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2016-08-08
- 2016-06-30: Marketable Securities, Current $15.63M.
- 2015-12-31: Marketable Securities, Current $0.00.
- 2013-09-30: Marketable Securities, Current $25.00M.
- 2013-06-30: Marketable Securities, Current $50.03M.
| Period end | Marketable Securities, Current |
|---|---|
| 2016-06-30 | $15.63M 10-Q · filed 2016-08-08 |
| 2015-12-31 | $0.00 10-Q · filed 2016-08-08 |
| 2013-09-30 | $25.00M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $50.03M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $0.00 10-Q · filed 2013-11-12 |
| 2012-09-30 | $18.92M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $17.12M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $15.00M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $0.00 10-Q · filed 2012-05-10 |
| 2011-09-30 | $40.18M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $55.00M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $0.00 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |